US3957755A
(en)
*
|
1967-10-18 |
1976-05-18 |
Rhone-Poulenc S.A. |
Naphthacene derivatives
|
US3965088A
(en)
*
|
1967-10-18 |
1976-06-22 |
Rhone-Poulenc S.A. |
Naphthacene derivatives
|
GB1322872A
(en)
*
|
1971-01-20 |
1973-07-11 |
Rhone Poulenc Sa |
Process for the preparation of antibiotics
|
FR2160716A1
(en)
*
|
1971-11-23 |
1973-07-06 |
Rhone Poulenc Sa |
Antibiotics duborimycin and 27706rp - by reduction of daunorubicin and adriamycin
|
GB1457632A
(en)
*
|
1974-03-22 |
1976-12-08 |
Farmaceutici Italia |
Adriamycins
|
US3976667A
(en)
*
|
1975-06-19 |
1976-08-24 |
The Upjohn Company |
Steffimycinone, 7-deoxysteffimycinone and derivatives
|
US4012448A
(en)
*
|
1976-01-15 |
1977-03-15 |
Stanford Research Institute |
Synthesis of adriamycin and 7,9-epiadriamycin
|
ES444380A1
(es)
*
|
1976-01-16 |
1977-06-16 |
Gosalvez Mario |
Un procedimiento para preparar derivados metalicos antraci- clinicos.
|
US4039736A
(en)
*
|
1976-04-15 |
1977-08-02 |
Bristol-Myers Company |
Antibiotic compounds marcellomycin and musettamycin
|
GB1509875A
(en)
*
|
1976-06-14 |
1978-05-04 |
Farmaceutici Italia |
Optically active anthracyclinones and anthracycline glycosides
|
US4192915A
(en)
*
|
1976-08-16 |
1980-03-11 |
Bristol-Myers Company |
Anthracycline glycosides from streptomyces
|
US4209588A
(en)
*
|
1976-10-05 |
1980-06-24 |
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai |
Process for producing new antitumor anthracycline antibiotics
|
NL176004C
(nl)
*
|
1976-10-05 |
1985-02-01 |
Microbial Chem Res Found |
Werkwijze ter bereiding van geneesmiddelen met antitumorwerking op basis van anthracycline glycosiden en werkwijze ter bereiding van daartoe dienende anthracycline glycosiden.
|
US4112071A
(en)
*
|
1977-01-10 |
1978-09-05 |
Bristol-Myers Company |
Antibiotic complex
|
US4089872A
(en)
*
|
1977-03-09 |
1978-05-16 |
The Upjohn Company |
Antibiotics steffimycinol and 7-deoxysteffimycinol and process for preparing the same
|
US4246399A
(en)
*
|
1977-03-21 |
1981-01-20 |
Interx Research Corporation |
Complexes of doxorubicin exhibiting enhanced stability
|
US4077844A
(en)
*
|
1977-03-30 |
1978-03-07 |
The Upjohn Company |
Process for preparing steffimycinol
|
NL7900869A
(nl)
*
|
1978-02-09 |
1979-08-13 |
Erba Farmitalia |
Anthracyclinenantibiotica.
|
US4248970A
(en)
*
|
1978-05-30 |
1981-02-03 |
Bristol-Myers Company |
Antibiotic complex producing bacterial culture
|
US4196127A
(en)
*
|
1978-06-01 |
1980-04-01 |
Research Corporation |
Anthracyclines
|
US4201773A
(en)
*
|
1978-07-26 |
1980-05-06 |
The United States Of America As Represented By The Department Of Health, Education And Welfare |
7-O-(2,6-Dideoxy-α-L-lyxo-hexopyranosyl)-daunomycinone, desmethoxy daunomycinone, adriamycinone, and carminomycinone
|
US4303785A
(en)
*
|
1978-08-05 |
1981-12-01 |
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai |
Antitumor anthracycline antibiotics
|
IT1196402B
(it)
*
|
1978-11-21 |
1988-11-16 |
Erba Farmitalia |
Antibiotici antitumorali
|
JPS5648893A
(en)
*
|
1979-09-07 |
1981-05-02 |
Sanraku Inc |
Preparation of anthracycline glycoside
|
US4348388A
(en)
*
|
1980-04-02 |
1982-09-07 |
G.D. Searle & Co. |
11-Amino-11-deoxydaunorubicin and analogs
|
JPS56156300A
(en)
*
|
1980-04-26 |
1981-12-02 |
Microbial Chem Res Found |
Novel preparative method of anthracyclin derivative
|
JPS5750994A
(en)
*
|
1980-09-12 |
1982-03-25 |
Microbial Chem Res Found |
Novel antibiotic mf266 substance and its preparation
|
JPS5756494A
(en)
*
|
1980-09-22 |
1982-04-05 |
Microbial Chem Res Found |
New anthracyclin derivative
|
JPS57163393A
(en)
*
|
1981-03-27 |
1982-10-07 |
Microbial Chem Res Found |
Novel anthracyclin derivative and its preparation
|
US4374979A
(en)
*
|
1981-04-27 |
1983-02-22 |
The University Of Kansas Endowment Association |
Regiospecific synthesis of anthracyclinone compounds such as daunomycinone
|
US4471052A
(en)
*
|
1982-01-18 |
1984-09-11 |
Adria Laboratories, Inc. |
Biosynthesis of simplified anthracyclines
|
GB2125030B
(en)
*
|
1982-08-13 |
1986-11-26 |
Erba Farmitalia |
Naphthacenequinone synthesis
|
US4562177A
(en)
*
|
1982-08-17 |
1985-12-31 |
The Ohio State University Research Foundation |
3'-Amino-2' halo-anthracycline antibiotics
|
US4548927A
(en)
*
|
1983-05-25 |
1985-10-22 |
Eaton John W |
Method and agents for raising animal tolerance to oxidant stress-inducing antibiotics
|
GB8426672D0
(en)
*
|
1984-10-22 |
1984-11-28 |
Erba Farmitalia |
Pharmaceutical compositions
|
US4610977A
(en)
*
|
1985-04-08 |
1986-09-09 |
The University Of Tennessee Research Corporation |
N-alkyl and N-benzyl adriamycin derivatives
|
US5124317A
(en)
*
|
1985-08-02 |
1992-06-23 |
Farmitalia Carlo Erba S.P.A. |
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
|
GB8519452D0
(en)
*
|
1985-08-02 |
1985-09-11 |
Erba Farmitalia |
Injectable solutions
|
US4863739A
(en)
*
|
1987-05-19 |
1989-09-05 |
Board Of Regents, The University Of Texas System |
Liposome compositions of anthracycline derivatives
|
EP0396626A1
(en)
*
|
1988-01-19 |
1990-11-14 |
Board Of Regents, The University Of Texas System |
Glycosides, liposomal compositions thereof, and methods for their use
|
GB8812697D0
(en)
*
|
1988-05-27 |
1988-06-29 |
Erba Carlo Spa |
Isolation & characterisation of genes resistant to anthracycline antibiotics
|
US5220001A
(en)
*
|
1989-10-25 |
1993-06-15 |
Zaidan Hojim Biseibutsu Dong-A Pharm Co. |
Anthracycline glycoside derivatives
|
KR100211417B1
(ko)
*
|
1990-11-30 |
1999-10-01 |
유충식 |
L-탈로피라노시드 유도체 및 그의 제조방법
|
DE4417865A1
(de)
*
|
1994-05-20 |
1995-11-23 |
Behringwerke Ag |
Kombination von Tumornekrose-induzierenden Substanzen mit Substanzen, die durch Nekrosen aktiviert werden, zur selektiven Tumortherapie
|
US6103236A
(en)
*
|
1995-05-10 |
2000-08-15 |
Kyowa Hakko Kogyo Co., Ltd. |
Toxin conjugates
|
DE69738815D1
(de)
|
1996-10-15 |
2008-08-14 |
Searle Llc |
Verwendung von Cyclooxygenase-2 Inhibitoren zur Behandlung und Vorbeugung von Neoplasia
|
US20030100532A1
(en)
|
1997-02-14 |
2003-05-29 |
Gary S. Jacob |
Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
|
US5948896A
(en)
*
|
1997-08-13 |
1999-09-07 |
Gem Pharmaceuticals |
Processes for preparing 13-deoxy anthracycline derivatives
|
ES2216327T3
(es)
|
1997-11-10 |
2004-10-16 |
G.D. SEARLE & CO. |
Uso de iminoazucares alquilados para tratar la resistencia a multiples a farmacos.
|
GB9727546D0
(en)
*
|
1997-12-31 |
1998-03-18 |
Pharmacia & Upjohn Spa |
Anthracycline glycosides
|
US6689759B1
(en)
|
1998-02-12 |
2004-02-10 |
G. D. Searle & Co. |
Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
|
JP2002502875A
(ja)
|
1998-02-12 |
2002-01-29 |
ジー・ディー・サール・アンド・カンパニー |
肝炎ウイルス感染症を処置するためのn−置換−1,5−ジデオキシ−1,5−イミノ−d−グルシトール化合物の使用
|
DE69922681T2
(de)
|
1998-10-16 |
2005-05-25 |
Mercian Corp. |
Kristallisation von doxorubicin-hydrochlorid
|
HK1043311A1
(zh)
*
|
1999-02-12 |
2002-09-13 |
G.D. Searle & Co. |
使用替代-1,5-二脱氧-1,5-亚氨基-d-glucitol化合物治疗肝炎病毒感染
|
JP2003505501A
(ja)
|
1999-02-12 |
2003-02-12 |
ジー・ディー・サール・アンド・カンパニー |
肝炎ウィルス感染の処置のためのグルカミン化合物
|
EP1261339A1
(en)
*
|
2000-02-14 |
2002-12-04 |
Pharmacia Corporation |
Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
|
US20060079463A1
(en)
*
|
2003-05-20 |
2006-04-13 |
Zhong Hong J |
Anticancer compositions comprising methenamine
|
US7314886B2
(en)
*
|
2003-10-02 |
2008-01-01 |
Cephalon, Inc. |
Tetrahydropyrano-indole derivatives
|
US8436190B2
(en)
|
2005-01-14 |
2013-05-07 |
Cephalon, Inc. |
Bendamustine pharmaceutical compositions
|
JP2008513519A
(ja)
*
|
2005-05-11 |
2008-05-01 |
シコール インコーポレイティド |
安定した凍結乾燥されたアントラサイクリングリコシド
|
JP2010505745A
(ja)
*
|
2006-10-06 |
2010-02-25 |
武田薬品工業株式会社 |
併用剤
|
AU2008324045B2
(en)
|
2007-11-09 |
2014-08-07 |
Affitech Research As |
Anti-VEGF antibody compositions and methods
|
AR072777A1
(es)
|
2008-03-26 |
2010-09-22 |
Cephalon Inc |
Formas solidas de clorhidrato de bendamustina
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
EP2189158A1
(en)
*
|
2008-11-20 |
2010-05-26 |
DKFZ Deutsches Krebsforschungszentrum, Stiftung des Öffentlichen Rechts |
Combination of rocaglamide and apoptosis inducing substances for the treatment of cancer
|
KR20110099138A
(ko)
*
|
2008-12-23 |
2011-09-06 |
파마셋 인코포레이티드 |
뉴클레오시드 포스포르아미데이트
|
US8716263B2
(en)
|
2008-12-23 |
2014-05-06 |
Gilead Pharmasset Llc |
Synthesis of purine nucleosides
|
TW201026716A
(en)
*
|
2008-12-23 |
2010-07-16 |
Pharmasset Inc |
Nucleoside analogs
|
EP2752422B1
(en)
|
2010-03-31 |
2017-08-16 |
Gilead Pharmasset LLC |
Stereoselective synthesis of phosphorus containing actives
|
DK3327148T3
(da)
|
2010-06-18 |
2021-04-12 |
Myriad Genetics Inc |
Fremgangsmåder til forudsigelse af status for brca1- og brca2-gener i en cancercelle
|
DK2609216T3
(en)
|
2010-08-24 |
2016-09-12 |
Dana Farber Cancer Inst Inc |
Methods to predict anti-cancer response
|
CN102363755B
(zh)
*
|
2011-05-21 |
2013-04-03 |
浙江海正药业股份有限公司 |
一种链霉菌及其生产阿霉素的方法
|
JP6117194B2
(ja)
|
2011-06-17 |
2017-04-19 |
ミリアド・ジェネティックス・インコーポレイテッド |
アレル不均衡を評価するための方法および材料
|
EP2794907B2
(en)
|
2011-12-21 |
2022-11-23 |
Myriad Genetics, Inc. |
Methods and materials for assessing loss of heterozygosity
|
EP4462120A3
(en)
|
2012-02-23 |
2025-01-08 |
Children's Medical Center Corporation |
Methods for predicting response to parp inhibitors
|
JP6104287B2
(ja)
|
2012-03-06 |
2017-03-29 |
天津和美生物技術有限公司 |
四環系アントラキノン誘導体
|
DK2859118T3
(en)
|
2012-06-07 |
2018-02-26 |
Inst Curie |
METHODS TO DETECT INACTIVATION OF THE HOMOLOGICAL RECOMBINATION ROAD (BRCA1 / 2) IN HUMAN TUMORS
|
CN103087124B
(zh)
*
|
2012-11-21 |
2016-01-13 |
浙江海正药业股份有限公司 |
一种制备阿霉素的方法
|
WO2014160080A1
(en)
|
2013-03-14 |
2014-10-02 |
Children's Medical Center Corporation |
Cancer diagnosis, treatment selection and treatment
|
CN105209037A
(zh)
*
|
2013-03-29 |
2015-12-30 |
雅沃科学有限责任公司 |
用于治疗癌症、神经障碍和纤维化病症的脂类呋喃、吡咯和噻吩化合物
|
PT2981624T
(pt)
|
2013-04-05 |
2020-03-23 |
Myriad Genetics Inc |
Métodos para avaliar deficiência na recombinação homóloga e prever resposta a tratamento para cancro
|
US11149316B2
(en)
|
2013-12-09 |
2021-10-19 |
Institut Curie |
Methods for detecting inactivation of the homologous recombination pathway (BRCA1/2) in human tumors
|
CN104774229A
(zh)
*
|
2014-01-10 |
2015-07-15 |
浙江华谱新创科技有限公司 |
一种阿霉素及其衍生物的制备方法
|
AU2015301390B2
(en)
|
2014-08-15 |
2021-08-26 |
Myriad Genetics, Inc. |
Methods and materials for assessing homologous recombination deficiency
|
WO2017189865A1
(en)
|
2016-04-27 |
2017-11-02 |
Avoscience, Llc |
Lipidic furan, pyrrole, and thiophene compounds for use in the treatment of atrophic vaginitis
|
CN107773556B
(zh)
*
|
2016-08-26 |
2020-08-18 |
广州安好医药科技有限公司 |
一种具有抗肿瘤药物功效的联合用药物
|
EP4141127B1
(en)
|
2021-08-30 |
2024-10-09 |
Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln |
Method for assessing homologous recombination deficiency in ovarian cancer cells
|